Stocks to Buy

Identifying winning stocks requires more than scanning headlines. InvestorPlace analysts focus on long-term themes, market timing, and structural shifts shaping where capital is flowing next, highlighting stocks positioned to benefit from those trends.

7 ‘A-Rated’ Aggressive Biotech Stocks to Gamble On

By Louis Navellier and the InvestorPlace Research Staff
The pandemic has raised awareness about the value of biotech across the world. In turn, these biotech stocks will benefit down the road.

3 Electric Vehicle Stocks Pushing the Envelope

By Ian Cooper, InvestorPlace Contributor
With plenty of pent-up demand for electric vehicles around the globe, here are three of the top electric car stocks to buy going forward.

Why Investors Should Buy Alphabet Stock on Weakness

By Larry Ramer, InvestorPlace Contributor
Alphabet stock is well-positioned to benefit from a surge of digital ads and multiple other positive catalyst in the coming months.

Facebook Stock Is Still a Great Buy into Extreme Fear

By Nicolas Chahine, InvestorPlace Contributor
Investors are always nervous about Facebook stock yet it keeps defying the odds. This is not changing soon so buy-the-dip remains right.

10 Stocks For Beginners To Buy Today For Profits Tomorrow

By Will Ashworth, InvestorPlace Contributor
The novel coronavirus and resulting quarantine led a lot of new investors to join in the markets. Here are 10 stocks for beginners to buy.

7 Travel Stocks to Buy Ahead of Renewed Demand in Tourism

By Joel Baglole, InvestorPlace Contributor
There are several stand out travel stocks to buy now, as each is bound to return with a vengeance in 2021 with the rise of tourism.

Pfizer Shares May Catch Momentum Soon From Vaccine Work

By Tezcan Gecgil, InvestorPlace Contributor
PFE's dividend yield as well as prospects for a Covid-19 vaccine should put Pfizer stock on the radar of long-term investors.

Bet Bullish on Uber Stock Despite Market Uneasiness

By Nicolas Chahine, InvestorPlace Contributor
The bullish thesis on Uber stock is still intact. The recent price action is still constructive and more mature than the indices. Own it.

The Mainstreaming of Cannabis Is Here and Canopy Growth Is a Strong Buy

By David Moadel, InvestorPlace Contributor
A famous lifestyle guru just took the plunge into cannabis-based goods. This is a win for the pro-hemp movement and for CGC stock holders.

Pfizer Is Your Best Bet at a Covid-19 Vaccine Play

By Muslim Farooque, InvestorPlace Contributor
Expect Pfizer to skyrocket come October as it attempts to produce a vaccine for the novel coronavirus in record time. PFE stock is a buy.

Amazon Still Looks Undervalued Thanks to Cash Flow

By Mark R. Hake, CFA
Amazon stock still looks undervalued here. AMZN stock is worth at least 25% more than today, given the power of its huge free cash flow.

AAPL Stock Hits The WFH Jackpot With Apple One And Fitness+

By Divya Premkumar, InvestorPlace Contributor
Apple’s big product revel did not feature the new iPhone but this should not deter investors from holding their position in Apple stock.

3 Biometric Stocks on the Cutting Edge

By Muslim Farooque, InvestorPlace Contributor
The three biometric stocks to buy in this article have unique competitive advantages setting them apart from the rest of the field.

Microsoft’s ZeniMax Deal Is a Win-Win

By Robert Waldo, InvestorPlace Senior Web Editor
Microsoft's $7.5 billion buyout of ZeniMax Media is a big win for MSFT stock; however, there are still a few nuances to consider moving forward.

At These Prices, It’s Time to Start Buying the Dip in Netflix Stock

By Luke Lango, InvestorPlace Senior Investment Analyst
Netflix is still Netflix. The only thing that changed in September is the NFLX stock price. And that stock price is now too low to ignore.

Costco Stock Is a Great All-Weather Buy for Every Investor

By Louis Navellier and the InvestorPlace Research Staff
The multi-year growth in Costco stock has been outstanding, and the everyday strength of consumer staples should keep it from slowing down.

5 High Yield Dividend Stocks Selling Below Their Tangible Book Value

By Mark R. Hake, CFA
5 high yield stocks selling below their tangible book value. These 5 dividend stocks have average upside of 79% along with 7.7% yields, or 40% annual total returns over 2 years.

This Billion-Dollar Acquisition Will Be Worth It for Ericsson Investors

By David Moadel, InvestorPlace Contributor
It's understandable if you want to hitch your wagon to 5G's future growth, and buying Ericsson stock is an easy way to do just that.

Moderna Stock Looks Like a Winner as the Covid-19 Vaccine Race Loosens

By Mark R. Hake, CFA
Moderna looks like it has a winner with its Covid-19 vaccine. MRNA stock could make $35 billion if it delivers 1 billion doses, making its $26 billion market cap look cheap.
Load More Articles